Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lori A. Leslie, Nilesh Gangan, Hiangkiat Tan & Qing Huang. (2022) Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia. Current Medical Research and Opinion 38:12, pages 2149-2161.
Read now
Read now
Stefano Molica, Valentina Gianfelici & Luciano Levato. (2020) Emerging bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia: one step ahead ibrutinib. Expert Opinion on Emerging Drugs 25:1, pages 25-35.
Read now
Read now
Ciprian Tomuleasa, Cristina Selicean, Sonia Cismas, Anca Jurj, Mirela Marian, Delia Dima, Sergiu Pasca, Bobe Petrushev, Vlad Moisoiu, Wilhelm-Thomas Micu, Anna Vischer, Kanza Arifeen, Sonia Selicean, Mihnea Zdrenghea, Horia Bumbea, Alina Tanase, Ravnit Grewal, Laura Pop, Carmen Aanei & Ioana Berindan-Neagoe. (2018) Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches. Critical Reviews in Clinical Laboratory Sciences 55:5, pages 329-345.
Read now
Read now
Eleni-Eirini Ladikou & Eva Kassi. (2017) The emerging role of estrogen in B cell malignancies. Leukemia & Lymphoma 58:3, pages 528-539.
Read now
Read now
Paula Cramer, Petra Langerbeins, Kirsten Fischer, Barbara Eichhorst, Michael Hallek & Valentin Goede. (2016) Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all?. Leukemia & Lymphoma 57:5, pages 987-990.
Read now
Read now
Tom Butler & John G Gribben. (2008) Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients. Expert Opinion on Medical Diagnostics 2:1, pages 101-112.
Read now
Read now
Articles from other publishers (64)
Javier Loscertales, Pau Abrisqueta-Costa, Antonio Gutierrez, José Ángel Hernández-Rivas, Rafael Andreu-Lapiedra, Alba Mora, Carolina Leiva-Farré, María Dolores López-Roda, Ángel Callejo-Mellén, Esther Álvarez-García & José Antonio García-Marco. (2023) Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study. Cancers 15:16, pages 4047.
Crossref
Crossref
André S. Santos, Jéferson P. de Andrade, Daniela A. Freitas, Érica S.D. Gonçalves, Douglas L. Borges, Lélia M. de A. Carvalho, Kenya V.M. de S. Noronha & Mônica V. Andrade. (2023) Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using a Semi-Markovian Model Approach in R. Value in Health Regional Issues 36, pages 10-17.
Crossref
Crossref
Cecilia Radkiewicz, Johanna B. Bruchfeld, Caroline E. Weibull, Mathias L. Jeppesen, Henrik Frederiksen, Mats Lambe, Lasse Jakobsen, Tarec C. El‐Galaly, Karin E. Smedby & Tove Wästerlid. (2022) Sex differences in lymphoma incidence and mortality by subtype: A population‐based study. American Journal of Hematology 98:1, pages 23-30.
Crossref
Crossref
Yang Yang, Yamin Shu, Guosong Chen, Yanchao Yin, Feie Li & Juan Li. (2022) A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax. PLOS ONE 17:12, pages e0278725.
Crossref
Crossref
Arathi Kunnumbrath, Neha Singh, Arvind Kumar Gupta, Nilotpal Chowdhury, Uttam Kumar Nath & Harish Chandra. (2022) Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers. Journal of Laboratory Physicians 14:04, pages 435-442.
Crossref
Crossref
Qing Huang, Kathleen L. Deering, Qing Harshaw & Lori A. Leslie. (2022) Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status. Advances in Therapy 39:7, pages 3292-3307.
Crossref
Crossref
Michał K. Zarobkiewicz & Agnieszka A. Bojarska-Junak. (2022) The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL). Cells 11:4, pages 661.
Crossref
Crossref
TalibMohammed Ameen & HaithemAhmed Al-Rubaie. (2022) Clinical significance of serum sCD23 and B-cell maturation antigen levels in patients with chronic lymphocytic leukemia. Iraqi Journal of Hematology 11:2, pages 134.
Crossref
Crossref
NuhuAndrew Yashim, DorcasYetunde Obazee, OlumideFaith Ajani, PaulOlaiya Abiodun, LoveAdeiye Ajani & FelixOlaniyi Sanni. (2022) Comparative study of hemostasis file in newly diagnosed leukemia patients and healthy persons at the Hematology and Blood Transfusion Department, National Hospital, Abuja. BLDE University Journal of Health Sciences 7:1, pages 68.
Crossref
Crossref
Hamzah El Baba, Ahmed Al Moudaris, Hayan Abo Samra, Layth Alateeg, Mohammed Al-Yaseen & Walid El Ansari. (2021) First case of chronic cell leukemia discovered incidentally in extra-saccular inguinal lymph node during laparoscopic bilateral inguinal hernia repair. Case report and literature review. International Journal of Surgery Case Reports 88, pages 106558.
Crossref
Crossref
Krish Patel & John M. Pagel. (2021) Current and future treatment strategies in chronic lymphocytic leukemia. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Fady Gh Haddad, Alain Chebly, Antoine El Sett, Hampig Raphael Kourie & Chantal Farra. (2021) An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib. Leukemia Research Reports 15, pages 100245.
Crossref
Crossref
M Graça Pereira, Isa Silva, Marta Pereira, Sara Faria, Bruna Silva, Sara Monteiro & Gabriela Ferreira. (2018) Unmet needs and quality of life in multiple myeloma patients. Journal of Health Psychology 25:10-11, pages 1717-1731.
Crossref
Crossref
Maximilian Koch, Sebastian Reinartz, Julia Saggau, Gero Knittel, Natascha Rosen, Oleg Fedorchenko, Lisa Thelen, Romy Barthel, Nina Reinart, Tamina Seeger-Nukpezah, Hans Christian Reinhardt, Michael Hallek & Phuong-Hien Nguyen. (2020) Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the Eµ-TCL1 Transgenic Mouse Model. Cancers 12:7, pages 1980.
Crossref
Crossref
Chukwuemeka A. Umeh, Pat Garcia-Gonzalez, David Tremblay & Richard Laing. (2020) The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP). EClinicalMedicine 19, pages 100257.
Crossref
Crossref
Margaux Wiber, Elsa Maitre, Jean-Marc Poncet, Virginie Duchenet, Gandhi Damaj, Edouard Cornet & Xavier Troussard. (2020) A population-based study of hairy cell leukemia over a period of 20 years. Cancer Treatment and Research Communications 25, pages 100236.
Crossref
Crossref
Xin Meng, Qing Min & Ji-Yang Wang. 2020. B Cells in Immunity and Tolerance. B Cells in Immunity and Tolerance
161
181
.
Safa Shukry, Fadhel Hariri & Abdul Wahab Al-Nehmi. 2019. Advances in Hematologic Malignancies. Advances in Hematologic Malignancies.
Michael Hallek. (2019) Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. American Journal of Hematology 94:11, pages 1266-1287.
Crossref
Crossref
Essohana Padaro, Yao Layibo, Irénée Délagnon Messanh Kueviakoe, Kossi Agbétiafa, Hèzouwè Magnang, Nicole Delali Akossiwa Koudokpo, Koffi Mawussi & Ahoefa Vovor. (2019) Caractéristiques de la leucémie lymphoïde chronique au Togo. Pan African Medical Journal 34.
Crossref
Crossref
Viggo Jønsson, Haneef Awan, Neil D. Jones, Tom B. Johannesen, Bjarni á Steig, Gudrid Andosdottir & Geir E. Tjønnfjord. (2019) Inheritance of Susceptibility to Malignant Blood Disorders. Scientific Reports 9:1.
Crossref
Crossref
Philipp G. Hemmati. (2018) Chronische Leukämien. CME 15:10, pages 9-22.
Crossref
Crossref
Barbara L. Andersen, Neha Godiwala Goyal, David M. Weiss, Travis D. Westbrook, Kami J. Maddocks, John C. Byrd & Amy J. Johnson. (2018) Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia. Cancer 124:15, pages 3240-3248.
Crossref
Crossref
Mehwesh Taj. (2017) Clinical and Laboratory Parameters in a Cohort of CLL Patient: A Single Centre Experience. Hematology & Transfusion International Journal 5:4.
Crossref
Crossref
Michael Hallek. (2017) Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 92:9, pages 946-965.
Crossref
Crossref
T. Jevtovic-Stoimenov, T. Cvetkovic, M. Despotovic, J. Basic, J. Cvetkovic, G. Marjanovic & D. Pavlovic. (2017) The influence of TNF alpha -308 G/A polymorphism on oxidative stress in patients with chronic lymphocytic leukemia. Leukemia Research 54, pages 66-72.
Crossref
Crossref
EmineKilic Bagir, Arbil Acikalin, Perihan Alsancak, Semra Paydas, Emel Gurkan & Melek Ergin. (2017) Prevalence of cytogenetic abnormalities in chronic lymphocytic leukemia in the southern part of Turkey. Indian Journal of Cancer 54:3, pages 572.
Crossref
Crossref
Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Abdoulaye Sène, Blaise Félix Faye, Moussa Seck, Macoura Gadji, Tandakha Ndiaye Dièye, Claire Mathiot, Sophie Reynaud, Saliou Diop & Martine Raphaël. (2016) Characteristics of chronic lymphocytic leukemia in Senegal. BMC Hematology 16:1.
Crossref
Crossref
Eleshia J. Morrison, Joseph M. Flynn, Jeffrey Jones, John C. Byrd & Barbara L. Andersen. (2016) Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia. Annals of Hematology 95:12, pages 1989-1997.
Crossref
Crossref
C da Cunha-Bang, J Simonsen, K Rostgaard, C Geisler, H Hjalgrim & C U Niemann. (2016) Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients. Blood Cancer Journal 6:11, pages e499-e499.
Crossref
Crossref
Suliman A. Alsagaby, Paul Brennan & Chris Pepper. (2016) Key Molecular Drivers of Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 16:11, pages 593-606.
Crossref
Crossref
Cristina Bagacean, Mihnea Zdrenghea, Adrian Tempescul, Victor Cristea & Yves Renaudineau. (2016) Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises. Immunotherapy 8:5, pages 569-581.
Crossref
Crossref
P. Baliakas, M. Mattsson, K. Stamatopoulos & R. Rosenquist. (2016) Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?. Journal of Internal Medicine 279:4, pages 347-357.
Crossref
Crossref
Paula Cramer, Michael Hallek & Barbara Eichhorst. (2016) State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. Oncology Research and Treatment 39:1-2, pages 25-32.
Crossref
Crossref
Paula Cramer, Petra Langerbeins, Barbara Eichhorst & Michael Hallek. (2016) Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG). European Journal of Haematology 96:1, pages 9-18.
Crossref
Crossref
Paula Cramer, Petra Langerbeins & Michael Hallek. (2016) Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia. The Cancer Journal 22:1, pages 62-66.
Crossref
Crossref
Manman Wei, Xiang Wang, Zilan Song, Mingkun Jiao, Jian Ding, Ling-Hua Meng & Ao Zhang. (2015) Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond. Medicinal Research Reviews 35:4, pages 720-752.
Crossref
Crossref
Michael Hallek. (2015) Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. American Journal of Hematology 90:5, pages 446-460.
Crossref
Crossref
Ryan Healey, Jay L. Patel, Lawrence de Koning & Christopher Naugler. (2015) Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada. Leukemia Research 39:4, pages 429-434.
Crossref
Crossref
Polina Shindiapina, Jennifer R. Brown & Alexey V. Danilov. (2014)
A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in
TP53
. British Journal of Haematology 167:2, pages 149-161.
Crossref
Crossref
E Gibiansky, L Gibiansky, D J Carlile, C Jamois, V Buchheit & N Frey. (2014) Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure-Response in CLL. CPT: Pharmacometrics & Systems Pharmacology 3:10, pages 144.
Crossref
Crossref
Chris L. Pashos, Christopher R. Flowers, Neil E. Kay, Mark Weiss, Nicole Lamanna, Charles Farber, Susan Lerner, Jeff Sharman, David Grinblatt, Ian W. Flinn, Mark Kozloff, Arlene S. Swern, Thomas K. Street, Kristen A. Sullivan, Gale Harding & Zeba M. Khan. (2013) Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Supportive Care in Cancer 21:10, pages 2853-2860.
Crossref
Crossref
Michael Hallek. (2013) Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment. American Journal of Hematology 88:9, pages 803-816.
Crossref
Crossref
Ines M. Macias-Perez & Ian W. Flinn. (2012) GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia. Current Hematologic Malignancy Reports 8:1, pages 22-27.
Crossref
Crossref
P Rebora, M Lee, K Czene, M G Valsecchi & M Reilly. (2012) High risks of familial chronic lymphatic leukemia for specific relatives: signposts for genetic discovery?. Leukemia 26:11, pages 2419-2421.
Crossref
Crossref
E.C. van den Broek, A.P. Kater, S.A.M. van de Schans, H.E. Karim-Kos, M.L.G. Janssen-Heijnen, W.G. Peters, P.T.G.A. Nooijen, J.W.W. Coebergh & E.F.M. Posthuma. (2012) Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989–2008. European Journal of Cancer 48:6, pages 889-895.
Crossref
Crossref
Oliver Schmetzer & Anne Flörcken. 2012. Sex and Gender Aspects in Clinical Medicine. Sex and Gender Aspects in Clinical Medicine
151
168
.
M. Sztankay, J. Giesinger & B. Holzner. (2012) Gender differences in quality of life in patients with haematological malignancies. memo - Magazine of European Medical Oncology 4:4, pages 224-226.
Crossref
Crossref
Christopher R. Friese, Craig C. Earle, Lysa S. Magazu, Jennifer R. Brown, Bridget A. Neville, Nathanael D. Hevelone, Lisa C. Richardson & Gregory A. Abel. (2010) Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer 117:7, pages 1470-1477.
Crossref
Crossref
Gregory A. Abel. (2011) The real world: CLL. Blood 117:13, pages 3481-3482.
Crossref
Crossref
Paula Cramer & Michael Hallek. (2010) Prognostic factors in chronic lymphocytic leukemia—what do we need to know?. Nature Reviews Clinical Oncology 8:1, pages 38-47.
Crossref
Crossref
Margaret Warner & Jan-Åke Gustafsson. (2010) The role of estrogen receptor β (ERβ) in malignant diseases—A new potential target for antiproliferative drugs in prevention and treatment of cancer. Biochemical and Biophysical Research Communications 396:1, pages 63-66.
Crossref
Crossref
Fatima Bhayat, Emma Das-Gupta, Chris Smith, Tricia McKeever & Richard Hubbard. (2009) The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer 9:1.
Crossref
Crossref
M.D. Seftel, A.A. Demers, V. Banerji, S.B. Gibson, C. Morales, G. Musto, M.W. Pitz & J.B. Johnston. (2009) High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort. Leukemia Research 33:11, pages 1463-1468.
Crossref
Crossref
Pau AbrisquetaArturo PereiraCiril Rozman, Marta Aymerich, Eva GinéCarol MorenoAna MuntañolaMaría Rozman, Neus Villamor, Kate HodgsonElías Campo, Francesc BoschEmili Montserrat. (2009) Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clínic of Barcelona experience. Blood 114:10, pages 2044-2050.
Crossref
Crossref
Welko Tomic & André Brouwers. (2009) Kwaliteit van leven en zingeving bij chronische lymfatische leukemie. Psychologie en Gezondheid 37:3, pages 134-144.
Crossref
Crossref
Nashwa Khayrat Abousamra, Manal Salah EL‐Din & Emad Azmy. (2009) T‐cell CD38 expression in B‐chronic lymphocytic leukaemia. Hematological Oncology 27:2, pages 82-89.
Crossref
Crossref
Femke Van Bockstaele, Bruno Verhasselt & Jan Philippé. (2009) Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews 23:1, pages 25-47.
Crossref
Crossref
M. Düchler. (2009) Menstruation protects women from B-cell chronic lymphocytic leukemia. Bioscience Hypotheses 2:4, pages 257-260.
Crossref
Crossref
J B Weinberg, A D Volkheimer, M Mihovilovic, N Jiang, Y Chen, K Bond, J O Moore, J P Gockerman, L F Diehl, C M de Castro, D A Rizzieri, M C Levesque, R DeKroon & W J Strittmatter. (2008) Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia 22:12, pages 2184-2192.
Crossref
Crossref
Hermann Brenner, Adam Gondos & Dianne Pulte. (2008) Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 111:10, pages 4916-4921.
Crossref
Crossref
R Walewska, A Majid, Z Davis, P Dusanjh, D B J Kennedy, D G Oscier & M J S Dyer. (2007) Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1–69. Leukemia 21:12, pages 2537-2538.
Crossref
Crossref
Versha Banerji, James B. Johnston & Matthew D. Seftel. (2007) The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia. Transfusion and Apheresis Science 37:1, pages 57-62.
Crossref
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
Crossref